Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Emran AA"'
Publikováno v:
Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 1139-1149 (2014)
Arafat Rahman Oany,1 Abdullah-Al Emran,1,2 Tahmina Pervin Jyoti3 1Department of Biotechnology and Genetic Engineering, Life Science Faculty, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh; 2Translational Research Institute, U
Externí odkaz:
https://doaj.org/article/ee08b7ffbaab412e9a6fc7d18601a31c
Autor:
Ravindran Menon D; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; Department of Medical Oncology, University of Colorado Denver, Aurora, CO, USA., Hammerlindl H; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Pharmaceutical Chemistry, The University of California, San Francisco, San Francisco, CA, USA., Gimenez G; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Hammerlindl S; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Pharmaceutical Chemistry, The University of California, San Francisco, San Francisco, CA, USA., Zuegner E; Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Institute for Biomedicine and Health Sciences, Graz, Austria., Torrano J; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Bordag N; Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Institute for Biomedicine and Health Sciences, Graz, Austria., Emran AA; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Giam M; Institute of Medical Biology, Agency for Science, Technology and Research, Immunos Singapore, Singapore., Denil S; Institute of Medical Biology, Agency for Science, Technology and Research, Immunos Singapore, Singapore., Pavelka N; SIgN, the Singapore Institute for Immunology, Agency for Science, Technology and Research, Immunos Singapore, Singapore., Tan AC; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA., Sturm RA; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Haass NK; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Rancati G; Institute of Medical Biology, Agency for Science, Technology and Research, Immunos Singapore, Singapore., Herlyn M; The Wistar Institute, Philadelphia, PA, USA., Magnes C; Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Institute for Biomedicine and Health Sciences, Graz, Austria., Eccles MR; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand., Fujita M; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; Denver VA Medical Center, Denver, CO, USA; Department of Immunology and Microbiology, University of Colorado Denver, Aurora, CO, USA., Schaider H; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia. Electronic address: h.schaider@uq.edu.au.
Publikováno v:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2023 Nov; Vol. 71, pp. 100993. Date of Electronic Publication: 2023 Aug 10.
Autor:
Hossain MA; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh., Al Ashik SA; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh., Mahin MR; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh., Al Amin M; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh., Rahman MH; Department of Computer Science and Engineering, Islamic University, Kushtia, 7003, Bangladesh., Khan MA; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh.; Department of Biotechnology and Genetic Engineering, University of Development Alternative, 4/4B, Block A, Lalmatia, Dhaka, 1209, Bangladesh., Emran AA; Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1092, Bangladesh.
Publikováno v:
Heliyon [Heliyon] 2022 Dec 22; Vol. 8 (12), pp. e12480. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2022).
Autor:
Ahmed F; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia., Tseng HY; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia., Ahn A; Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Gunatilake D; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia., Alavi S; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia., Eccles M; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand., Rizos H; Melanoma Institute Australia, Sydney, Australia; Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia., Gallagher SJ; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia., Tiffen JC; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia., Hersey P; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia. Electronic address: peter.hersey@sydney.edu.au., Emran AA; Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, Australia; Melanoma Institute Australia, Sydney, Australia; Central Clinical School, The University of Sydney, Camperdown, Australia; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2022 May; Vol. 142 (5), pp. 1444-1455.e10. Date of Electronic Publication: 2021 Oct 22.
Autor:
Emran AA; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Fisher DE; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: dfisher3@mgh.harvard.edu.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2022 Apr; Vol. 142 (4), pp. 1004-1006. Date of Electronic Publication: 2022 Feb 04.
Autor:
Alavi S; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia.; Melanoma Epigenetics Lab, The Centenary Institute, University of Sydney, Camperdown 2050, Australia., Emran AA; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia.; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02114, USA., Tseng HY; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia.; Melanoma Epigenetics Lab, The Centenary Institute, University of Sydney, Camperdown 2050, Australia., Tiffen JC; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia.; Melanoma Epigenetics Lab, The Centenary Institute, University of Sydney, Camperdown 2050, Australia., McGuire HM; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Ramaciotti Facility for Human Systems Biology, University of Sydney, Sydney 2050, Australia.; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney 2050, Australia., Hersey P; Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia.; Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jan 10; Vol. 14 (2). Date of Electronic Publication: 2022 Jan 10.
Autor:
Emran AA; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Tseng HY; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Gunatilake D; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Cook SJ; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Ahmed F; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Wang S; Centre for Drug Discovery and Development, Cancer Research Institute, University of South Australia, Adelaide, Australia., Hersey P; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Gallagher SJ; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Tiffen JC; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address: j.tiffen@centenary.org.au.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2021 Sep; Vol. 141 (9), pp. 2238-2249.e12. Date of Electronic Publication: 2021 Mar 26.
Autor:
Punnia-Moorthy G; Melanoma Oncology and Immunology Group, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Epigenetics Laboratory, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia., Hersey P; Melanoma Oncology and Immunology Group, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia., Emran AA; Melanoma Oncology and Immunology Group, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia., Tiffen J; Melanoma Oncology and Immunology Group, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Epigenetics Laboratory, Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
Publikováno v:
Frontiers in genetics [Front Genet] 2021 Jun 16; Vol. 12, pp. 680633. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Autor:
Huang JC; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Emran AA; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Endaya JM; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., McCaughan GW; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.; AW Morrow GE & Liver Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Gorrell MD; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Zhang HE; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 01; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 01.
Autor:
Emran AA; Melanoma Oncology and Immunology Program, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia., Gallagher SJ; Melanoma Oncology and Immunology Program, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia., Tiffen JC; Melanoma Oncology and Immunology Program, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia., Hersey P; Melanoma Oncology and Immunology Program, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia. peter.hersey@sydney.edu.au.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (7), pp. 1184-1186. Date of Electronic Publication: 2021 Jan 19.